PPS14 PCMV

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePPS14 PCMV

Drug Alias Name13-valent pneumococcal PCMVpneumococcal capsular polysaccharide 14-dominant negative inhibitor protein capsular matrix vaccine (Matrivax)PPS14-DNI PCM

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMatrivax Research & Development Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMatrivax Research & Development Corp

Active IndicationsN/A

Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A